Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Cited by 40
Related Papers
Enhanced efficacy of histone deacetylase inhibitor panobinostat combined with dual PI3K/mTOR inhibitor BEZ235 against glioblastoma.
|PubMed|2019|24
<p>Effective Inhibition of <em>MYC</em>-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1</p>
|Cancer Management and Research|2020|6